New possibilities for symptomatic treatment of allergic rhinitis-Reference-Cited by-同舟云学术

New possibilities for symptomatic treatment of allergic rhinitis

Published:2019-04-28 Issue:6 Volume: Page:64-67
ISSN:2658-5790
Container-title:Medical Council
language:
Short-container-title:Med. sov.

Author:

Ryazantsev S. V.¹,Krivopalov A. A.¹,Rebrova S. A.²,Krivopalova L. I.²

Affiliation:

1. Federal State Budgetary Institution «Saint-Petersburg Research Institute of Ear, Throat, Nose and Speech» of the Ministry of Health of the Russian Federation

2. ANO «Polyclinic of St. Petersburg Metro»

Abstract

Allergic rhinitis is one of the most common human diseases and causes a deterioration of the quality of life. The prevalence of allergic rhinitis in the Russian Federation and in the world has increased significantly. The main pharmacological group in the treatment of allergic rhinitis is the 2nd generation antihistamines with high affinity for H1-receptors. The article presents an overview of the new representative of the abovementioned group of drugs - the drug bilastine (Nixar®).

Publisher

Remedium, Ltd.

Subject

General Medicine

Reference19 articles.

1. Lopatin A.S. Rhinitis. Moscow: Literra. 2010. (In Russ.)

2. Goryachkina L.A., Kashkin E.P., Terekhova E.P. et al. Clinical Allergology and Immunology: A Guide for Practitioners. Edited by L.A. Goryachkina and E.P. Kashkina. M.: Miklosh, 2009: 121. (In Russ.)

3. Bousquet J., Khaltaev N., Cruz A.A. et al. Allergic Rhinitis and its impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA²LEN and AllerGen. Allergy. 2008;63(Suppl. 86):8-160.

4. Vasilevsky I.V. Rehabilitation of children and teenagers with diseases of respiratory organs, digestive organs, kidneys, cardiovascular system and allergic diseases in the conditions of polyclinic. Minsk: BelMAPO, 2007:157-171. (In Russ.)

5. WHO Informational Bulletin № 310 (July 2015). WHO. Global Health Observatory database. Available at: http://www.who.int/gho/database/ru/ (In Russ.)